CAS 168010-17-1: 2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one,5-hydroxy-2,2-dimethyl-10-(3-methyl-2-buten-1-yl)-

Eriosematin is a bioactive compound, which is a naturally occurring flavonoid isolated from the plant Eriosema laurentii, known for its ethnopharmacological use. It exerts its mode of action through selective inhibition of specific enzymes involved in inflammatory pathways, potentially targeting cyclooxygenase (COX) and lipoxygenase (LOX) activity. This inhibitory action reduces the synthesis of pro-inflammatory mediators, thereby exhibiting potent anti-inflammatory and antioxidant properties. The uses and applications of Eriosematin are primarily focused on its potential as a therapeutic agent in inflammatory-related conditions, leveraging its natural origin and specific molecular targets. It is of significant interest in pharmacological research for the development of novel treatments for diseases characterized by inflammation, such as rheumatoid arthritis and other chronic inflammatory disorders. Researchers in biomedical sciences are investigating its efficacy and safety profiles, utilizing various in vitro and in vivo models to explore its therapeutic potential and facilitate the development of new anti-inflammatory drugs.

Eriosematin has anti-proliferative and apoptosis-inducing properties and is a compound extracted from the root of Flemingia philippinensis in the Philippines.